4th Virtual Clinical Trials

A year ago, virtual clinical trials were a high-interest curiosity; now, they are essential to your pipeline. COVID-19 has forced more trials to be conducted virtually, and this has the potential to reveal new innovations and improve the patient experience. But how can we ensure this new age of decentralized trials will bring lasting benefits to clinicians, sponsors, and patients, while also accelerating time-to-market?

Switching to virtual trials requires more than just running standard methods in front of a webcam. Your entire clinical approach must be reconceptualized in order to get the most benefit from a virtual approach. Lack of industry-wide standards is the biggest barrier to collecting and leveraging patient data; each pharma company or vendor may have their own set of systems or safety tools, and integrating these can be a huge obstacle for your pipeline.

You cannot afford to miss the 4th Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on this subject, offering you exclusive insights our speaking faculty hasn’t shared anywhere else!

Top Reasons to Attend

A roadmap for turning urgent responses to COVID into permanent new processes that will keep your momentum going
Best practice on updating SOPs for these unprecedented problems
Strategies to maintain patient centricity, safety and feedback throughout the trial
Up-to-date review of new assessments and expectations from regulators
Key techniques for collaborating around new data standards with service providers